sivelestat has been researched along with Myocardial Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bessho, R; Fujii, M; Kambe, M; Ochi, M; Shimizu, K | 1 |
| Akiyama, D; Cho, S; Hara, T; Maekawa, T; Sumikawa, K; Yoshitomi, O | 1 |
2 other study(ies) available for sivelestat and Myocardial Ischemia
| Article | Year |
|---|---|
Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia.
Topics: Acetylcholine; Animals; Cardiotonic Agents; Coronary Circulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Glycine; In Vitro Techniques; Leukocyte Elastase; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Perfusion; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Sulfonamides; Troponin T; Vasodilator Agents; Ventricular Function, Left; Ventricular Pressure | 2009 |
Postischemic infusion of sivelestat sodium hydrate, a selective neutrophil elastase inhibitor, protects against myocardial stunning in swine.
Topics: Animals; Coronary Circulation; Female; Glycine; Interleukin-6; Male; Myocardial Ischemia; Myocardial Stunning; Proteinase Inhibitory Proteins, Secretory; Sulfonamides; Swine | 2010 |